<正>CAS researchers have launched a 48.16-million-yuan project to address the eco-environmental setting of Qinghai Lake. Its kick-off meeting was held on 29 and
<正>As the first US FDA-approved monclonal antibody drug for the treatment of B-cell lymphomas and later on for the treatment of autoimmune diseases, Rituximab
<正>Under the auspices of the CAS Academic Divisions (CASAD), a meeting convened on 30 May in Beijing to address a research project on water resources. Chaired